Note: Ingredients listed on restricted chemical lists
EC/CAS
63-42-3
Name of the chemical
Lactose C12H22O11
Concentration
N/A
General Information
Revision date
2007-09-11
Product name
Meridia Capsules
Product Synonyms
Reductil
Manufacturer Name
Abbott Laboratories
Emergency telephone
1(800) 424-9300 (in USA and Canada) or Access Code + (703) 527-
Icons in SDS
Company Information
company name
Abbott Laboratories
Section 2
SECTION 2: Hazards identification
Emergency Overview: White to off-white powder in a capsule. Odorless. No data are available to evaluate the health risk of this material.
Principle Routes of Exposure
Oral: Clinical Route Dermal: Not determined. Inhalation: Not determined. Hazard Information: Ingestion Rating: Not determined. Skin Absorption Rating: Not determined. Inhalation Rating: Not determined. Corrosiveness Rating: Not determined. Skin Contact Rating: Not determined. Skin Sensitization Rating: Not determined. Eye Contact Rating Not determined Target Organs: Respiratory System, Cardiovascular System , Nervous System. Carcinogenicity Rating: Ingredients Percent OSHA: NTP: IARC: ACGIH: Lactose. Proprietary Not Listed. Cellulose Microcrystalline. Proprietary Not Listed. Sibutramine Hydrochloride Proprietary Not Listed. Monohydrate. Magnesium Stearate. Proprietary Not Listed.
NFPA Ratings
Not determined. Signs and Symptoms: None known from occupational exposure. Clinical data suggests the following: headaches, fast heart rate, increased blood pressure, rash, drowsiness, dizziness, diarrhea, nasal discharge, constipation.
Medical Conditions Generally Aggravated by Exposure
None known from occupational exposure. Medical conditions exacerbated due to exposure to the following organs: cardiovascular system, gastrointestinal system, respiratory system. Concurrent use of medications.
